Sign Up to like & get
recommendations!
2
Published in 2022 at "Histopathology"
DOI: 10.1111/his.14780
Abstract: Emerging evidence indicates that breast cancer (BC) patients whose tumours express HER2 protein without HER2 gene amplification (HER2‐low), can benefit from antibody–drug conjugates (ADC). However, the current definition of HER2‐low BC remains incomplete with low…
read more here.
Keywords:
breast cancer;
her2 low;
her2;
definition her2 ... See more keywords